JC Pharma SRL
JC Pharma reported total assets of €1.75m at the end of the 2025 financial year (annual accounts filed with the NBB on 12 Jun 2026).
The score of JC Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +105 % Total assets +110 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
JC Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 12 Jun 2026
- Year ended 31 Dec 2024filed on 17 Jun 2025
- Year ended 31 Dec 2023filed on 21 Aug 2024
- Year ended 31 Dec 2022filed on 06 Jul 2023
- Year ended 31 Dec 2021filed on 13 Jun 2022
JC Pharma's financial analysis
- Solvency69.2%sector median: 55.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of JC Pharma
JC Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0460.070.010
- VAT number
- BE0460070010
- Peppol
- Registered · 0208:0460070010 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 19 Feb 1997
- Registered office
- 1180 Uccle
- Latest accounts
- 2025 · filed on 12 Jun 2026
- Activity
- Market research and public opinion polling (NACE 73200)
JC Pharma (SRL) has been based in Uccle since 1997, active in: market research and public opinion polling. For 2025, it reports a net profit of 216,126 € and equity of €1.21m; its revenue is not published. Its solvency stands at 69.2%, above the median of its sector (55.4%).
Companies similar to JC Pharma
Companies in the same business, of comparable size and area, outside its group.
- Société Internationale d'Etudes et de Coopération au Développement Market research and public opinion polling Braine-le-Château · balance sheet 210,917 €
- Antares Management Market research and public opinion polling Woluwe-Saint-Pierre · balance sheet €1.65m
- IMO - CAR Market research and public opinion polling Anderlecht · balance sheet €2.31m
- Objet B'ART Market research and public opinion polling Hasselt · balance sheet €1.96m
- Belcom Market research and public opinion polling Ixelles · balance sheet €1.81m
- Evoluteam Market research and public opinion polling Uccle · balance sheet 76,120 €
- Ring Pharma Market research and public opinion polling Grimbergen · balance sheet €1.57m
- Nordoss Market research and public opinion polling Destelbergen · balance sheet 936,178 €
Frequently asked questions about JC Pharma
What is the revenue of JC Pharma?
JC Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of JC Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0460070010 for JC Pharma, if the company is VAT-registered. Its company number (CBE) is 0460.070.010.
Where is the registered office of JC Pharma?
According to the CBE register, the registered office of JC Pharma is in 1180 Uccle.
What is the equity of JC Pharma?
At the close of the 2025 financial year, the equity of JC Pharma amounts to 1,213,138 €, a solvency of 69.2% of total assets.
Who manages JC Pharma?
The register lists 2 active mandates at JC Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of JC Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →